Global Perspectives on Gynecologic Malignancies at ESMO 2022

Expert perspectives and strategic insights on the latest therapeutic developments and translational research coming out of ESMO regarding gynecologic malignancies.

September 24, 2022


Robert Coleman, MD

MD Anderson Cancer Center, Houston, TX, USA

Faculty Members

Bradley Monk, MD
St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA

David O’Malley, MD 
The Ohio State University College of Medicine, Columbus, OH, USA

Matthew Powell, MD
Washington University School of Medicine, St. Louis, MO, USA

Mansoor Mirza, MD
Copenhagen University Hospital, Denmark

Jalid Sehouli, MD
Charité Comprehensive Cancer Center, Berlin, Germany

Domenica Lorusso, MD, PhD
Catholic University of Rome, Italy

Sample Report

Start discovering the insights

View Report


  • Early-Stage Ovarian Cancer
  • Advanced Ovarian Cancer: First-Line Therapy
  • Advanced Ovarian Cancer: Optimal Maintenance Therapy – What Do We Know Today? 
  • Advanced Ovarian Cancer: Treatment Strategies in the Relapsed Setting
  • Advanced Endometrial Cancer: Current Treatment and Future Directions  
  • Advanced Cervical Cancer: Current Treatment and Future Directions

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.